Naar www.iknl.nl
- Gynaecologie > Cervixcytologie
Notificatie richtlijn E-mail richtlijn Naar startpagina oncoline
----------

Laatst gewijzigd: 2016-11-01, Versie: 1.0, Verantwoording: Nederlandse Vereniging Voor Pathologie, Type: Landelijke richtlijn

Referentielijst

1 - Nadim B (2013)
Nadim B, Beckmann M. Do we perform too many procedures for cervical dysplasia in young women? J Low Genit Tract Dis. 2013 Oct;17(4):385-9. doi: 10.1097/LGT.0b013e31827ccea9.
 
2 - Quint KD (2013)
Quint KD, de Koning MN, Quint WG, et al. Progression of cervical low grade squamous intraepithelial lesions: in search of prognostic biomarkers. Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):501-6. doi: 10.1016/j.ejogrb.2013.07.012. Epub 2013 Aug 2.
 
3 - Vale DB (2013)
Vale DB, Westin MC, Zeferino LC. High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion. Cancer Cytopathol. 2013 Oct;121(10):576-81. doi: 10.1002/cncy.21312. Epub 2013 Jun 13.
 
4 - Abati A (1998)
Abati A, Jaffurs W, Wilder AM. Squamous atypia in the atrophic cervical vaginal smear. Cancer cytopathology. 1998;84(4):218-25.
 
5 - Alaghehbandan R (2013)
Alaghehbandan R. Performance of the CellSolutions Glucyte liquid-based cytology in comparison with the ThinPrep and SurePath methods. Acta Cytol. 2013;57(2):189-97. doi: 10.1159/000345878. Epub 2013 Feb 28.
 
6 - Arbyn M (2015)
Arbyn M, Snijders PJ, Meijer CJ, et al. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect. 2015 Sep;21(9):817-26.
 
7 - Arbyn M (2014)
Arbyn M, Verdoodt F, Snijders PJ M, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014 Feb;15(2):172-83.
 
8 - Baker A (1995)
Baker A, Melcher D, Smith R. Role of re-screening of cervical smears in internal quality control. J Clin Pathol. 1995 Nov;48(11):1002-4.
 
9 - Benoy IH (2011)
Benoy IH, Vanden Broeck D, Ruymbeke MJ, et al. Prior knowledge of HPV status improves detection of CIN2+ by cytology screening. Am J Obstet Gynecol. 2011 Dec;205(6):569.e1-7.
 
10 - Bergeron C (2015)
Bergeron C, Giorgi-Rossi P, Cas F, et al. Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial. J Natl Cancer Inst. 2015 Jan 7;107(2). pii: dju423. doi: 10.1093/jnci/dju423. Print 2015 Feb
 
11 - Bhatla N (2012)
Bhatla N, Puri K, Kriplani A, et al. Adjunctive testing for cervical cancer screening in low resource settings. Aust N Z J Obstet Gynaecol. 2012 Apr;52(2):133-9. doi: 10.1111/j.1479-828X.2011.01402.x. Epub 2012 Jan 25.
 
12 - Bhatla N (2007)
Bhatla N, Mukhopadhyay A, Kriplani A, et al. Evaluation of adjunctive tests for cervical cancer screening in low resource settings. Indian J Cancer. 2007 Apr-Jun;44(2):51-5.
 
13 - Bibbo M (2008)
Bibbo M, Wilbur DC. Comprehensive cytopathology. 3rd ed. / edited by Marluce Bibbo, David Wilbur. ed. Philadelphia, PA ; Oxford: Elsevier Saunders; 2008
 
14 - Bos AB (2001)
Bos AB, van Ballegooijen M, Elske van den Akker-van Marle M, et al. Endocervical Status Is Not Predictive of the Incidence of Cervical Cancer in the Years After Negative Smears. Am J Clin Pathol 2001;115(6):851-5
 
15 - Bosch FX (2002)
Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002 Apr;55(4):244-65.
 
16 - Bulk S (1996)
Bulk S, Van Kemenade FJ, Rozendaal L, et al. The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol. 2004 Apr;57(4):388-93.
 
17 - Bulten J (2000)
Bulten J, de Wilde PC, Schijf C, et al. Decreased expression of Ki-67 in atrophic cervical epithelium of post-menopausal women. J Pathol. 2000a Apr;190(5):545-53.
 
18 - Bulten J (2000)
Bulten J, de Wilde PC, Boonstra H, et al. Proliferation in ‘atypical’ atrophic pap smears. Gynecol Oncol. 2000b Nov;79(2):225-9.
 
19 - Celik C (2008)
Celik C, Gezginç K, Toy H, et al., A comparison of liquid-based cytology with conventional cytology. Int J Gynaecol Obstet. 2008 Feb;100(2):163-6. Epub 2007 Oct 24.
 
20 - Cernescu EC (2013)
Cernescu EC, Anton G, Ru?? S, et al. The effectiveness of cytological rescreening in the reduction of false negative/positive Pap reports. Roum Arch Microbiol Immunol. 2013 Apr-Jun;72(2):93-104.
 
21 - Constandinou-Williams C (2010)
Constandinou-Williams C, Collins SI, Roberts S, et al. Is human papillomavirus viral load a clinically useful predictive marker? A longitudinal study. Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):832-7.
 
22 - Fontaine D (2012)
Fontaine D, Narine N, Naugler C. Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis. BMJ Open. 2012 Apr 13;2(2):e000847. doi: 10.1136/bmjopen-2012-000847. Print 2012.
 
23 - Gosvig CF (2015)
Gosvig CF, Huusom LD, Deltour I, et al. Role of human papillomavirus testing and cytology in follow-up after conization. Acta Obstet Gynecol Scand. 2015;94(4):405-11.
 
24 - Gupta S (2006)
Gupta S, Kumar N, Singhal N, et al. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy. Diagn Cytopathol. 2006 Oct;34(10):676-81
 
25 - Herbert A (2007)
Herbert A, Bergeron C, Wiener H, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology. Cytopathology. 2007 Aug;18(4):213-9.
 
26 - IARC (2008)
IARC. European guidelines for quality assurance in cervical cancer screening. Second Edition. 2008, International Agency for Research on Cancer.
 
27 - IARC 2015 (2015)
IARC 2015
 
28 - Kaminski PF (1989)
Kaminski PF, Sorosky JI, Wheelock JB, et al. The significance of atypical cervical cytology in an older population. Obstet Gynecol. 1989 Jan;73(1):13-5.
 
29 - Katki HA (2013)
Katki HA, Gage JC, Schiffman M, et al. Follow-up testing after coloposcopy: five year risk of CIN2+ after a colposcopic diagnosis of CIN1 or less. J Low Gen Tr Dis, 2013; 5: S69-S77.
 
30 - Kitchener HC (2015)
Kitchener HC, Gittins M, Desai M, et al. A study of cellular counting to determine minimum thresholds for adequacy for liquid-based cervical cytology using a survey and counting protocol. Health Technol Assess. 2015 Mar;19(22):i-xix, 1-64
 
31 - Kjr SK (2010)
Kjær SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010 Oct 6;102(19):1478-88. doi: 10.1093/jnci/djq356. Epub 2010 Sep 14
 
32 - Kocken M (2012)
Kocken M, Uijterwaal MH, de Vries AL, et al. High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis. Gynecol Oncol. 2012;125(2):500-7.
 
33 - Kurman RJ (2011)
Kurman RJ, Ronnett BM, Hedrick Ellenson L. Blaustein's pathology of the female genital tract. 6th ed. / edited by Robert J. Kurman, Brigitte M. Ronnett, Lora Hedrick Ellenson. ed. New York ; London: Springer; 2011
 
34 - Manrique EJ (2006)
Manrique EJ, Amaral RG, Souza NL, et al., Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure. Cytopathology. 2006 Jun;17(3):116-20
 
35 - Massad LS (2012)
Massad LS, Einstein MH, Huh WK, et al, for the 2012 ASCCP consensus Guidelines Conference. J Low Gen Tr Dis, vol 17, 5: 2013, S1-S27).
 
36 - Meijer CJ (2009)
Meijer CJ, Berkhof J, Castle PE et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer. 2009 Feb 1;124(3):516-20.
 
37 - Moriarty AT (2014)
Moriarty AT, Nayar R, Arnold T, et al. The Tahoe Study: bias in the interpretation of Papanicolaou test results when human papillomavirus status is known. Arch Pathol Lab Med. 2014 Sep;138(9):1182-5.
 
38 - Nadim B (2013)
Nadim B, Beckmann M. Do we perform too many procedures for cervical dysplasia in young women? J Low Genit Tract Dis. 2013 Oct;17(4):385-9. doi: 10.1097/LGT.0b013e31827ccea9.
 
39 - NHSCSP 2003 (2003)
NHSCSP Publication No. 14: January 2003: A Guide for Laboratories Participating in the NHS Cervical Screening Programme
 
40 - Pajtler M (2002)
Pajtler M, Audy-Jurkovi? S. Pap smear adequacy--is the assessing criterion including endocervical cells really valid? Coll Antropol. 2002 Dec;26(2):565-70
 
41 - Programme (2013)
Programme, N.C.S., Achievable standards, Benchmarks for reporting, and Criteria for evaluating cervical cytopathology, in third edition including revised performance indicators. 2013, NHS.
 
42 - NHS Cervical Screening Programme 1996 (1996)
Quality Assurance Guidelines for the Cervical Screening Programme. NHS Cervical Screening Programme, 1996
 
43 - Quint KD (2013)
Quint KD, de Koning MN, Quint WG, et al. Progression of cervical low grade squamous intraepithelial lesions: in search of prognostic biomarkers. Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):501-6. doi: 10.1016/j.ejogrb.2013.07.012. Epub 2013 Aug 2.
 
44 - Report of the Working Party (1995)
Report of the Working Party on Internal Quality Control. The Scottish Office, 1995
 
45 - Robinson 2015 (2015)
Robinson 2015 (Cancer (Cancer Cytopathol) 2015;000:000000
 
46 - Rozemeijer K (2016)
Rozemeijer K, Penning C, Siebers AG, et al., Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II detection rates. Cancer Causes Control. 2016 Jan;27(1):15-25. doi: 10.1007/s10552-015-0678-1. Epub 2015 Oct 12.
 
47 - Siebers AG (2014)
Siebers AG, Arbyn M, Melchers WJ, et al., Effectiveness of two strategies to follow-up ASC-US and LSIL screening results in The Netherlands using repeat cytology with or without additional hrHPV testing: a retrospective cohort study. Cancer Causes Control. 2014 Sep;25(9):1141-9.
 
48 - Siebers AG (2013)
Siebers AG, van der Laak JAWM, Huberts-Manders R, et al. Accurate estimation of the cellularity of cervical liquid-based cytology. Cytopathology. 2013 Aug;24(4):216-21.
 
49 - Siebers AG (2012)
Siebers AG, Landelijke evaluatie B3j- Effect van een verandering in de praktijkrichtlijn. 2012, ruco.
 
50 - Siebers AG (2012)
Siebers AG, Klinkhamer PJ, Vedder JE, et al. J. Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology. Arch Pathol Lab Med. 2012 Jan;136(1):76-83. doi: 10.5858/arpa.2011-0113-OA.
 
51 - Siebers AG (2009)
Siebers AG, Klinkhamer PJ, Grefte JM, et al., Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA. 2009 Oct 28;302(16):1757-64.
 
52 - Siebers AG (2006)
Siebers AG, Verbeek AL, Massuger LF, et al. Normal appearing endometrial cells in cervical smears of asymptomatic postmenopausal women have predictive value for significant endometrial pathology. Int J Gynecol Cancer. 2006 May-Jun;16(3):1069-74.
 
53 - Siebers AG (2003)
Siebers AG, de Leeuw H, Verbeek AL, et al. Prevalence of squamous abnormalities in women with a recent smear without endocervical cells is lower as compared to women with smears with endocervical cells. Cytopathology. 2003 Apr;14(2):58-65.
 
54 - Snijders PJ (2003)
Snijders PJ, van den Brule AJ, Meijer CJ. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol. 2003 Sep;201(1):1-6.
 
55 - Solomon D (2001)
Solomon D, Davey D, Kurman R, et al., The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002 Apr 24;287(16):2114-9.
 
56 - Strander B (2007)
Strander B, Andersson-Ellström A, Milsom I, et al., Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study. Cancer. 2007 Oct 25;111(5):285-91
 
57 - Sturgis CD (2013)
Sturgis CD, Schaaf MR, Tickman RJ. Focused rescreening of NILM Pap slides from women >/= 30 years of age with positive high risk HPV DNA: an enhanced quality control measure. Diagn Cytopathol. 2013 May;41(5):399-403.
 
58 - Suckling J (2006)
Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001500
 
59 - Tavares SB (2008)
Tavares SB, Alves de Sousa NL, Manrique EJ, et al., Comparison of the performance of rapid prescreening, 10% random review, and clinical risk criteria as methods of internal quality control in cervical cytopathology. Cancer. 2008 Jun 25;114(3):165-70.
 
60 - Utagawa ML (2008)
Utagawa ML, Shirata NK, Mattosinho de Castro Ferraz Mda G, et al., Performance of 3 methods for quality control for gynecologic cytology diagnoses. Acta Cytol. 2008 Jul-Aug;52(4):439-44.
 
61 - Vale DB (2013)
Vale DB, Westin MC, Zeferino LC. High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion. Cancer Cytopathol. 2013 Oct;121(10):576-81. doi: 10.1002/cncy.21312. Epub 2013 Jun 13.
 
62 - Wright AM (2013)
Wright AM, Smith D, Dhurandhar B, et al. Digital slide imaging in cervicovaginal cytology: a pilot study. Arch Pathol Lab Med. 2013 May;137(5):618-24.
 
63 - Wright PK (2010)
Wright PK, Marshall J, Desai M, et al. Comparison of SurePath(R) and ThinPrep(R) liquid-based cervical cytology using positive predictive value, atypical predictive value and total predictive value as performance indicators. Cytopathology. 2010 Dec;21(6):374-8. doi: 10.1111/j.1365-2303.2010.00772.x.
 
64 - Tan JHJ (2013)
Tan JHJ, Garland SM, Tabrizi SN, et al. Hybrid capture II testing for high-risk human papillomavirus DNA in the Follow-up of women treated for high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2013 Jul;17(3):308-14.
 
65 - Taylor S (2011)
Taylor S, Wang C, Wright TC, et al. A comparison of human papillomavirus testing of clinician-collected and self-collected samples during follow-up after screen-and-treat. Int J Cancer. 2011 Aug 15;129(4):879-86.
 
66 - The Bethesda System (2014)
The Bethesda System for Reporting Cervical Cytology. Definitions, Criteria, and Explanatory Notes. Nayar R, Wilbur D.C.(eds) 3th ed Springer 2014
 
67 - ThinPrep
ThinPrep test morphology- Reference Atlas, Hologic, Editor.